Back to Search
Start Over
Darolutamide plus androgen-deprivation therapy (ADT) in patients with high-risk biochemical recurrence (BCR) of prostate cancer: A phase 3, randomized, double-blind, placebo-controlled study (ARASTEP).
- Source :
- Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, pTPS254-TPS254, 235p
- Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 0732183X
- Volume :
- 42
- Database :
- Supplemental Index
- Journal :
- Journal of Clinical Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 175074430
- Full Text :
- https://doi.org/10.1200/JCO.2024.42.4_suppl.TPS254